Relativity Acquisition Corp: The Merger is a Go

If you follow Relativity Acquisition Corp (ticker: RACY), there is finally a major update. The company has cleared the biggest hurdle in its journey to go public. Here is the plain-English breakdown of what this means for you.

1. What happened?

On March 25, 2026, Relativity shareholders officially voted to approve the merger with Instinct Bio Technical Company Inc.

Think of this as the "green light." Shareholders also removed a rule requiring the company to keep $5 million in tangible assets. By waiving this, Relativity can finish the merger even if investors withdraw their cash from the trust account. This removes a major technical barrier to closing the deal.

2. Why does this matter?

Relativity started as a "blank check" company (a SPAC) holding $115 million while searching for a business to buy. By approving this merger, shareholders have decided the search is over.

The company is now transitioning from a "shell" company into an active business. You are moving from holding a stake in a pile of cash to owning a piece of a biotech company focused on gene-editing and therapeutic delivery.

3. What about the money?

Some investors chose not to stay for the merger. A small group of shareholders asked for their money back instead of staying invested.

Specifically, holders of 15,279 shares cashed out at roughly $12.62 per share. This removed about $192,821 from the trust account. However, this is a very low withdrawal rate, signaling strong support for the deal. The company keeps most of its cash to fund Instinct Bio Technical’s upcoming clinical trials and laboratory expansion.

4. Who is affected?

• Current Shareholders: You are now an investor in Instinct Bio Technical. Your ownership percentage will be reduced as more shares are issued to sponsors and through performance-based bonuses.
• The Market: Traders are watching closely because the uncertainty of the search phase is over. The focus now shifts to the company's "cash runway"—how long the remaining money will last before they need to raise more funds.

5. What happens next?

• The Closing: The merger should officially close within the next 5–10 business days.
• Stock Transition: Watch your brokerage account. The ticker symbol will change from "RACY" to "IBTC." Your shares will automatically convert to represent ownership in the new company.
• Volatility: Now that the deal is approved, the stock price will depend on how the market feels about Instinct Bio Technical’s future, specifically their FDA filings and the success of their lead drug.

6. A quick tip for traders

The "will they or won't they" phase is over. Your strategy should shift. You are no longer betting on a management team’s ability to find a deal; you are now betting on the success of the business. Instinct Bio Technical is in the high-risk, high-reward biotech sector.

Decision Checklist:

• Check your risk tolerance: Biotech stocks are notoriously volatile. Are you prepared for the price swings that come with clinical trial results?
• Watch the ticker: Keep an eye out for the transition to "IBTC" in your brokerage account over the next two weeks.
• Review the pipeline: Since you are now a biotech investor, look up Instinct Bio Technical’s specific drug pipeline. Their future value depends entirely on whether those drugs make it through the FDA approval process.